Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

SPARC stimulates neuronal differentiation of medulloblastoma cells via the Notch1/STAT3 pathway.

Bhoopathi P, Chetty C, Dontula R, Gujrati M, Dinh DH, Rao JS, Lakka SS.

Cancer Res. 2011 Jul 15;71(14):4908-19. doi: 10.1158/0008-5472.CAN-10-3395. Epub 2011 May 25.

2.

Cathepsin B facilitates autophagy-mediated apoptosis in SPARC overexpressed primitive neuroectodermal tumor cells.

Bhoopathi P, Chetty C, Gujrati M, Dinh DH, Rao JS, Lakka S.

Cell Death Differ. 2010 Oct;17(10):1529-39. doi: 10.1038/cdd.2010.28. Epub 2010 Mar 26.

3.

Nitric oxide suppresses transforming growth factor-beta1-induced epithelial-to-mesenchymal transition and apoptosis in mouse hepatocytes.

Pan X, Wang X, Lei W, Min L, Yang Y, Wang X, Song J.

Hepatology. 2009 Nov;50(5):1577-87. doi: 10.1002/hep.23156.

PMID:
19821529
4.

MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.

Garzia L, Andolfo I, Cusanelli E, Marino N, Petrosino G, De Martino D, Esposito V, Galeone A, Navas L, Esposito S, Gargiulo S, Fattet S, Donofrio V, Cinalli G, Brunetti A, Vecchio LD, Northcott PA, Delattre O, Taylor MD, Iolascon A, Zollo M.

PLoS One. 2009;4(3):e4998. doi: 10.1371/journal.pone.0004998. Epub 2009 Mar 24.

5.

SPARC in cancer biology: its role in cancer progression and potential for therapy.

Tai IT, Tang MJ.

Drug Resist Updat. 2008 Dec;11(6):231-46. doi: 10.1016/j.drup.2008.08.005. Epub 2008 Oct 11. Review.

PMID:
18849185
6.

Signaling pathways in medulloblastoma.

Guessous F, Li Y, Abounader R.

J Cell Physiol. 2008 Dec;217(3):577-83. doi: 10.1002/jcp.21542. Review.

PMID:
18651559
7.

The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host.

Podhajcer OL, Benedetti L, Girotti MR, Prada F, Salvatierra E, Llera AS.

Cancer Metastasis Rev. 2008 Sep;27(3):523-37. doi: 10.1007/s10555-008-9135-x. Review.

PMID:
18459035
8.

Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells.

Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang QC, Zhang YJ, Lu R, Chen YX, Fang JY.

Neoplasia. 2008 Mar;10(3):287-97.

9.

SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated.

Haber CL, Gottifredi V, Llera AS, Salvatierra E, Prada F, Alonso L, Sage EH, Podhajcer OL.

Int J Cancer. 2008 Apr 1;122(7):1465-75. Erratum in: Int J Cancer. 2008 Jul 1;123(1):245. Helene, Sage E [corrected to Sage, E Helene].

10.

Normalization of the ovarian cancer microenvironment by SPARC.

Said N, Socha MJ, Olearczyk JJ, Elmarakby AA, Imig JD, Motamed K.

Mol Cancer Res. 2007 Oct;5(10):1015-30.

11.

CDC25 phosphatases in cancer cells: key players? Good targets?

Boutros R, Lobjois V, Ducommun B.

Nat Rev Cancer. 2007 Jul;7(7):495-507. Review.

PMID:
17568790
12.
13.

Outcome of children with posterior fossa medulloblastoma: a single institution experience over the decade 1994-2003.

Kombogiorgas D, Sgouros S, Walsh AR, Hockley AD, Stevens M, Grundy R, Peet A, English M, Spooner D.

Childs Nerv Syst. 2007 Apr;23(4):399-405. Epub 2006 Nov 22.

PMID:
17119978
15.
16.

Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.

Lin Q, Lai R, Chirieac LR, Li C, Thomazy VA, Grammatikakis I, Rassidakis GZ, Zhang W, Fujio Y, Kunisada K, Hamilton SR, Amin HM.

Am J Pathol. 2005 Oct;167(4):969-80.

17.

Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells.

Yuan J, Yan R, Krämer A, Eckerdt F, Roller M, Kaufmann M, Strebhardt K.

Oncogene. 2004 Jul 29;23(34):5843-52.

PMID:
15208674
18.

The STATs of cancer--new molecular targets come of age.

Yu H, Jove R.

Nat Rev Cancer. 2004 Feb;4(2):97-105. Review. No abstract available.

PMID:
14964307
19.
20.

Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer.

Scholz A, Heinze S, Detjen KM, Peters M, Welzel M, Hauff P, Schirner M, Wiedenmann B, Rosewicz S.

Gastroenterology. 2003 Sep;125(3):891-905.

PMID:
12949733

Supplemental Content

Support Center